Shilpa Grover, MD; Matthew J. Hamilton , MD; David L. Carr-Locke MD, FRCP, FACG, FASGE Series Editor: David L. Carr-Locke MD, FRCP, FACG, FASGE

Disclosures

May 29, 2007

Approach to Management and Clinical Outcome

Vancomycin enemas were started and treatment with oral vancomycin and intravenous metronidazole were continued without improvement. The patient continued to have abdominal pain and now also had intermittent low-grade fevers. One dose of intravenous immune globulin (IVIG) was administered, with an improvement in diarrhea symptoms within 36 hours of administration. Six weeks after the onset of symptoms, the patient's diarrhea has resolved, with normalization of her white blood cell count and renal function. She has been discharged and is currently on a prolonged taper of oral vancomycin and a 1-month course of oral metronidazole.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....